| 发明名称 |
ORAL SUSPENSION OF PREDNISOLONE ACETATE |
| 摘要 |
The present invention relates to novel oral suspension formulation comprising prednisolone acetate, a pharmaceutically acceptable vehicle and a thickening agent. The present invention further provides a method of treating patients in need of prednisolone with the novel formulation.
|
| 申请公布号 |
US2012238534(A1) |
申请公布日期 |
2012.09.20 |
| 申请号 |
US201213483273 |
申请日期 |
2012.05.30 |
| 申请人 |
ASOTRA SATISH;GAO SHEN;YACOBI AVRAHAM;TARO PHARMACEUTICAL NORTH AMERICA, INC. |
发明人 |
ASOTRA SATISH;GAO SHEN;YACOBI AVRAHAM |
| 分类号 |
A61K31/573;A61P1/00;A61P5/00;A61P7/00;A61P7/10;A61P17/00;A61P25/00;A61P29/00;A61P35/00;A61P37/08;C07J5/00 |
主分类号 |
A61K31/573 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
